This company has been marked as potentially delisted and may not be actively trading. Aerie Pharmaceuticals (AERI) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AERI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of DirectorsSeptember 2, 2025 | finance.yahoo.comROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsightMarch 25, 2025 | finance.yahoo.comUS to donate 1 million mpox vaccine doses to halt outbreak in AfricaSeptember 26, 2024 | reuters.comGlobal $20B+ Macular Degeneration Treatment Market Outlook, 2024-2029: AI Integration Paves the Way for Personalized CareMay 10, 2024 | finance.yahoo.com20 Countries With Worst Vision ProblemsFebruary 29, 2024 | uk.finance.yahoo.comParatus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive OfficerFebruary 21, 2024 | finance.yahoo.comJustin Timberlake is ready to Rock Your Body for one night only in Memphis, and for freeJanuary 12, 2024 | msn.comAlcon’s dry eye drug achieves primary endpoints in Phase III trialsJanuary 10, 2024 | msn.comCurative Biotechnology, Inc.: Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsJanuary 8, 2024 | finanznachrichten.deCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsJanuary 8, 2024 | markets.businessinsider.comGlaucoma Therapeutics Market Size Projected to Reach USD 13.5 billion by 2031, With 5.5% CAGR: Transparency Market Research, Inc.December 15, 2023 | finance.yahoo.comGlobal Over the Counter (OTC) Drugs Market Size to Grow USD 265 Billion by 2032 | CAGR of 5.0%November 28, 2023 | finance.yahoo.comAerie’s Black Friday Sale is here —Save 40% off sitewide for a limited timeNovember 25, 2023 | nypost.comNNetarsudil for Fuchs Endothelial Corneal Dystrophy (FECD), 2019-2023 Emerging Drug Insights and Forecasts to 2032November 23, 2023 | finance.yahoo.comGlobal Glaucoma Treatment Market Size To Grow USD 10.5 Billion by 2032 | CAGR of 5.0%November 23, 2023 | finance.yahoo.comOpthea Limited: Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOOctober 27, 2023 | finanznachrichten.deOpthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOOctober 27, 2023 | markets.businessinsider.comRetinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsightOctober 23, 2023 | finance.yahoo.comRising Glaucoma Cases Forecast a Strong Optic Nerves Disorder Treatment MarketSeptember 25, 2023 | uk.finance.yahoo.comOptic Nerves Disorder Treatment Market Rises: North America Takes the HelmSeptember 13, 2023 | benzinga.comAerie Promo CodesAugust 25, 2023 | time.comTAngina Pectoris Drugs Global Market Report 2023August 24, 2023 | uk.finance.yahoo.comOcular Hypertension Treatment Global Market Report 2023August 24, 2023 | uk.finance.yahoo.comAlcon (ALC) Gains From Robust Contact Lense Sales, LaunchesJuly 18, 2023 | msn.comVillageMD Welcomes Richard Rubino as Chief Financial OfficerJune 27, 2023 | finance.yahoo.comThe Glaucoma Therapeutics market's size, share, and revenue will be thoroughly examined, with an anticipated CAGR of 13% increase from 2023 to 2030.June 22, 2023 | marketwatch.comI-Mab Announces the Appointment of Raj Kannan as CEOJune 22, 2023 | uk.finance.yahoo.comI-Mab Names Raj Kannan CEO - Quick FactsJune 22, 2023 | markets.businessinsider.comOphthalmic Drugs Global Market Report 2023June 8, 2023 | uk.finance.yahoo.comAlcon (ALC) Vision Care Sales Robust, Margin Pressure PersistsMay 17, 2023 | msn.comGlaucoma Therapeutics Market Size and Growth Analysis 2023-2031 by Absolute Reports with [121 Pages] in Pharmaceuticals SectorMay 17, 2023 | marketwatch.comOptic Nerves Disorder Treatment Market Size Fundamentals And Forecast Analysis 2023-2030May 17, 2023 | marketwatch.comOphthalmology Therapeutics Market 2023: Global Opportunity Analysis by Revenue, Gross Margin, Market ShareMay 16, 2023 | marketwatch.com2030 Vision: Ophthalmology Drugs Market Value to Hit New HeightsMay 5, 2023 | marketwatch.comAnophthalmia and Microphthalmia Treatment Market Share, Size and Value Analysis with growing 5.3% CAGR during period 2023 to 2030May 5, 2023 | marketwatch.comGlaucoma Therapeutics Market Trend Analysis, Future Demand, Updates (2023-2030)May 4, 2023 | marketwatch.comRho Kinases Inhibitor Market 2023 Precise Outlook – Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis AG, AERIE PHARMACEUTICALSMay 4, 2023 | marketwatch.comMindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing StrategyMay 2, 2023 | uk.news.yahoo.comGlaucoma Treatment Market Upcoming Trends, Size, Key Players, Revenue, Share, and Forecast 2023 to 2031May 2, 2023 | marketwatch.comWave-Front Aberrometer Market Research 2023 Growth, Trends, Outlook and Future Scope Analysis 2031April 28, 2023 | marketwatch.comGlaucoma and Dry Eye Diseases Market Research Analysis 2023-2031April 27, 2023 | marketwatch.com2023 to 2030, Rho Associated Protein Kinase 2 Market DemandApril 27, 2023 | marketwatch.comAerie Pharma Falls on Glaucoma Eye Drop Safety ConcernsApril 26, 2023 | thestreet.comCAGR of 7.7% | Global Fuchs Endothelial Corneal Dystrophy Market Size To Grow USD 360 Billion By 2032April 20, 2023 | finance.yahoo.comGlobal Glaucoma Therapeutics Market to Reach $7.2 Billion by 2030April 14, 2023 | finance.yahoo.comOphthalmology Therapeutics Market Data Source, And Forecast 2030April 13, 2023 | marketwatch.com2023 Rho Associated Protein Kinase 2 Market Share and Latest Growth Demand Status: Trends Analysis and Industry Expansion StrategiesApril 7, 2023 | marketwatch.comRho Associated Protein Kinase 2 Market Growth Predictions and Forecast 2030April 5, 2023 | marketwatch.comROCK2 Inhibitor Market 2023-2028: Future UpdatesMarch 28, 2023 | marketwatch.comGlobal Nystagmus Market Size by Application (Hospitals & Clinics, Research Centers) Forecast from 2023 to 2028March 27, 2023 | marketwatch.com Get Aerie Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AERI Media Mentions By Week AERI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AERI News Sentiment▼0.000.92▲Average Medical News Sentiment AERI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AERI Articles This Week▼00▲AERI Articles Average Week Get the Latest News and Ratings for AERI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aerie Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PRME News Today PLX News Today IKT News Today IZTC News Today CVM News Today ZIVO News Today CRTX News Today ALVR News Today AIM News Today NKGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AERI) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerie Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerie Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AERI Stock Alerts